Your basket is currently empty!
EU follows US & approves Keytruda for 1st line RCC
Merck & Co/MSD’s PD-1 inhibitor Keytruda received FDA approval earlier in 2019 for use alongside Pfizer’s ...
News Archive
MSD
Our work depends on donations from generous people so that we can support those affected by kidney cancer.
Would you like to support our work through a donation?
